Drug Markets/Zanamivir

Zanamivir

1 NDC across 1 manufacturer|0 Generic,1 Brand

Zanamivir is used to treat human influenza, per the National Library of Medicine's MED-RT classification.

▸ More about this market

The brand product was first FDA-approved on Jul 26, 1999. In 2024, Medicare Part D spent $13K on Zanamivir across 194 claims for 114 beneficiaries.

Zanamivir is available as 1 NDC from 1 manufacturer (0 generic, 1 brand), with NADAC prices from $2.83 to $2.83 per EA. Every pack size and labeler in this drug market is compared side-by-side below.

Total NDCs

1

0G / 1B

Manufacturers

1

competing in market

Price Spread

$2.83 – $2.83

per EA

7d Activity

1 flat

avg +0.0% WoW · of 1 NDCs

Market Price Trend

Monthly average NADAC per unit, split by generic and brand.

Explore this market from other angles

Move from the molecule page into the supplier, class, and trend views that create the strongest internal-link cluster for this market.

Manufacturer Breakdown

1 manufacturer producing ZANAMIVIR

Drug Portfolio

1 NDCs total, 1 shown

Drug ↕Price 7d Change ↕
RELENZA 5 MG DISKHALER
$2.8319
per EA
—

Frequently Asked Questions

What is Zanamivir used to treat?

Zanamivir is used to treat human influenza, per the National Library of Medicine's MED-RT classification.

How much does Medicare spend on Zanamivir?

In 2024, Medicare Part D spent $13K on Zanamivir across 194 claims for 114 beneficiaries.

How many Zanamivir products are on the market?

The Zanamivir drug market contains 1 NDC from 1 manufacturer — 0 generic and 1 brand product.

What is the price range for Zanamivir?

NADAC reference prices for Zanamivir range from $2.8319 to $2.8319 per EA.

Which manufacturers make Zanamivir?

1 manufacturer lists Zanamivir in NADAC. Ranked by number of NDCs, the largest are GlaxoSmithKline LLC (1).